alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › p-tau

p-tau

10 studies tagged p-tau, dated 2014-01-01 to 2025-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease 2025-04-01
  2. Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia 2023-09-05
  3. Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia 2021-04-07

Studies

10 studies carry this tag.

Date range

2014 to 2025

Top journals

  • ACS chemical neuroscience 1
  • AJNR. American journal of neuroradiology 1
  • Ageing research reviews 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Brain and behavior 1

10 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A comparison of p-tau assays for the specificity to detect tau changes in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-04-01 Biomarkers

    LMW-specific p-tau assays could be more useful in the diagnostic workup of AD, especially in population-based communities where conditions causing peripheral neuropathy are frequent.

  2. Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Nature communications 2023-09-05 Biomarkers

    Preeclampsia (PE) is the leading cause of maternal and fetal mortality globally and may trigger dementia later in life in mothers and their offspring.

  3. Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. ACS chemical neuroscience 2021-04-07 Biomarkers

    Beta-amyloid (Aβ 1-42 ) triggers the phosphorylation of tau protein in Alzheimer's disease (AD), but the relationship between phosphorylated tau (p-tau) and Aβ 1-42 in the blood is not elucidated.

  4. Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Ageing research reviews 2020-11-04 Genetics

    Alzheimer's disease (AD) is a progressive and synaptic failure disease.

  5. Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Journal of neurology, neurosurgery, and psychiatry 2020-07-01 Biomarkers

    The assessment of serum NfL and p-Tau 181 may provide a comprehensive view of FTLD, aiding in the differential diagnosis, in staging disease severity and in defining survival probability.

  6. Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. European journal of nuclear medicine and molecular imaging 2020-04-14 Brain scans and imaging

    Regional [ 18 F]flortaucipir BP ND correlated stronger with cognition and neurodegeneration than CSF p-tau, suggesting that tau PET more accurately reflects disease severity in AD.

  7. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Journal of neuroinflammation 2018-11-03 TREM2 and immune genetics

    The findings reinforce the involvement of neuroinflammation in delirium, yet with separate responses in patients with or without pre-existing dementia.

  8. Neurodegenerative disease biomarkers Aβ1-40, Aβ1-42, tau, and p-tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Brain and behavior 2018-01-13 Biomarkers

    Overall, these results support the vervet as a non-human primate model of amyloid-related neurodegeneration, such as Alzheimer's disease and cerebral amyloid angiopathy, and highlight Aβ 1-40 and p-tau 181 as potentially valuable biomarkers of these processes.

  9. Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. AJNR. American journal of neuroradiology 2015-07-30 Biomarkers

    The distribution of microbleeds revealed different associations with amyloid-β and phosphorylated tau 181 protein levels and cognition.

  10. Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2014-01-01 Biomarkers

    Our results support the use of the Aβ42/Aβ40 ratio in addition to the usual CSF AD biomarkers for patients with ambiguous biological profiles.

All topic tags with their study counts